BOARD of DIRECTORS
Cognos Therapeutics Inc.’s Board of Directors is comprised of leading individuals from business, medical research and scientific technology fields. Each serves as part of the company’s governing body and custodians of the company’s financial interests. Each member of the board assumes the responsibility to initiate and establish the policies to further the company’s goals and ambitions as well as to maintain a fiduciary responsibility for the investors.
Roger D. Kornberg, PhD
Dr. Roger Kornberg is a Co-Founder at Cognos Therapeutics, Inc and serves as a corporate strategic planning advisor to the CEO and the Board of Directors. Dr. Kornberg is a Nobel prize-winning American biochemist. He currently teaches and performs research at the Stanford University School of Medicine where he is a professor of structural biology.
Richard Alan Lerner, MD
Dr. Lerner is a leading authority in biomedical research. He is the Lita Annenberg Hazen Professor of Immunochemistry in the Department of Molecular Biology of The Scripps Research Institute.
Thomas Chen, MD, PhD
Eli Gang, MD, FACC, FACP